Dystrophin Threshold Level Necessary for Normalization of Neuronal Nitric Oxide Synthase, Inducible Nitric Oxide Synthase, and Ryanodine Receptor-Calcium Release Channel Type 1 Nitrosylation in Golden Retriever Muscular Dystrophy Dystrophinopathy-Reference-Cited by-同舟云学术

Dystrophin Threshold Level Necessary for Normalization of Neuronal Nitric Oxide Synthase, Inducible Nitric Oxide Synthase, and Ryanodine Receptor-Calcium Release Channel Type 1 Nitrosylation in Golden Retriever Muscular Dystrophy Dystrophinopathy

Published:2016-09 Issue:9 Volume:27 Page:712-726
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Gentil Christel¹,Le Guiner Caroline²³,Falcone Sestina¹,Hogrel Jean-Yves⁴,Peccate Cécile¹,Lorain Stéphanie¹,Benkhelifa-Ziyyat Sofia¹,Guigand Lydie⁵,Montus Marie³,Servais Laurent⁴,Voit Thomas¹,Piétri-Rouxel France¹

Affiliation:

1. Sorbonne Universités, UPMC Univ Paris 06/INSERM/CNRS/Institut de Myologie/Centre de Recherche en Myologie (CRM), GH Pitié Salpêtrière, Paris, France

2. Atlantic Gene Therapies/INSERM UMR 1089 Université de Nantes, CHU de Nantes, IRT1, Nantes, France

3. Généthon, Evry, France

4. Institut de Myologie, GH Pitié-Salpêtrière, Paris, France

5. Atlantic Gene Therapies/INRA UMR 703, ONIRIS, Nantes-Atlantic National College of Veterinary Medicine, Food Science, and Engineering, Nantes, France.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.2016.041

Reference44 articles.

1. Dystrophin: The protein product of the duchenne muscular dystrophy locus

2. Duchenne muscular dystrophy: Pathogenetic aspects and genetic prevention

3. Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase

4. Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study

5. Modification of splicing in the dystrophin gene in cultured Mdx muscle cells by antisense oligoribonucleotides

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CRISPR-Based Gene Editing Techniques in Pediatric Neurological Disorders;Pediatric Neurology;2024-04

2. COVID-19 Mimics Pulmonary Dysfunction in Muscular Dystrophy as a Post-Acute Syndrome in Patients;International Journal of Molecular Sciences;2022-12-24

3. Genetic correction strategies for Duchenne muscular dystrophy and their impact on the heart;Progress in Pediatric Cardiology;2021-12

4. Toward the correction of muscular dystrophy by gene editing;Proceedings of the National Academy of Sciences;2021-04-30

5. The lncRNA 44s2 Study Applicability to the Design of 45-55 Exon Skipping Therapeutic Strategy for DMD;Biomedicines;2021-02-20